IC
AMGN icon

IKE Capital’s Amgen AMGN Stock Holding History

IKE Capital’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.84M Sell
5,073
-357
-7% -$122K 0.97% 31
2026
Q1 		$1.91M Sell
5,430
-76
-1% -$27.1K 1.08% 25
2025
Q4 		$1.8M Buy
+5,506
New +$1.75M 1.57% 19

Other funds holding AMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

IKE Capital's AMGN Position: Q2 2026 in Review

IKE Capital reduced its Amgen (AMGN) stake by 6.6% in Q2 2026, selling an estimated $122K and leaving 5,073 shares worth $1.84M. The position accounts for 0.97% of the portfolio, ranked #31.

IKE Capital first reported a position in AMGN in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.91M in Q1 2026. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • IKE Capital held 5,073 shares of Amgen worth $1.84M as of Q2 2026.
  • IKE Capital sold 357 Amgen shares in Q2 2026, an estimated $122K.
  • Amgen made up 0.97% of IKE Capital's portfolio in Q2 2026, its #31 holding.
  • IKE Capital first reported a position in Amgen in Q4 2025 and has held it in 3 quarters since.
  • IKE Capital's Amgen position peaked at $1.91M in Q1 2026.
  • 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on IKE Capital's 13F filing for Q2 2026, filed 16 Sep 2026.